Imperva to Present at Upcoming Investor Conferences

REDWOOD SHORES, Calif.--(BUSINESS WIRE)-- Imperva, Inc. (NYSE: IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced scheduled participation at the following upcoming investor conferences:

• Stifel Technology, Internet & Media Conference in San Francisco, CA – Anthony Bettencourt, President, CEO and Chairman of the Board and Terry Schmid, CFO to present on Monday, June 6, 2016 at 4:45 p.m. Pacific Time (7:45 p.m. Eastern Time)
• Stephens Spring Investment Conference in New York, NY – Anthony Bettencourt, President, CEO and Chairman of the Board and Terry Schmid, CFO to present on Wednesday, June 8, 2016 at 11:00am Eastern Time (8:00 a.m. Pacific Time)

A live webcast, as well as the replay, of these presentations will be accessible from the investors page of the Imperva’s website at www.imperva.com.

About Imperva

Imperva® (NYSE: IMPV) is a leading provider of cyber security solutions that protect business-critical data and applications. The company’s SecureSphere, CounterBreach, Incapsula and Skyfence product lines enable organizations to discover assets and risks, protect information wherever it lives – in the cloud and on-premises – and comply with regulations. The Imperva Defense Center, a research team comprised of some of the world’s leading experts in data and application security, continually enhances Imperva products with up-to-the minute threat intelligence, and publishes reports that provide insight and guidance on the latest threats and how to mitigate them. Imperva is headquartered in Redwood Shores, California. Learn more: www.imperva.com, our blog, on Twitter.

© 2016 Imperva, Inc. All rights reserved. Imperva, the Imperva logo, SecureSphere, CounterBreach, Incapsula and Skyfence are trademarks of Imperva, Inc. and its subsidiaries.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160601005290/en/

Investor Relations
For Imperva, Inc.
Kim Janssen, 650-832-6897
[email protected]
or
Seth Potter, 646-277-1230
[email protected]
[email protected]

Source: Imperva, Inc.

You May Also Be Interested In

• Stifel Starts Arrowhead Pharma (ARWR) at Buy
• WISeKey Reports Unaudited Preliminary H1 2026 Key Metrics; Revenue Up 115%, FY 2026 Guidance Reaffirmed
• Zypero Intellect Joins AI Verify Foundation to Advance Trusted Enterprise AI Governance